Evidence map›Paper›PMID 38543873›Full record

ArticleVaccines2024

IgG Serum Antibodies to

Valeria Asato, Ravit Bassal, Shiri Meron-Sudai, Sophy Goren, Lital Keinan-Boker, Calman A MacLennan, Dani Cohen

Open access · goldAbstract read
In one paragraph

Article in Vaccines, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.9field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. A multifunctional anti-O-Antigen human monoclonal antibody protects againstProceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  2. mBio · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Valeria AsatoDepartment of Epidemiology and Preventive Medicine, School of Public Health, Faculty of Medicine, Tel Aviv University, Tel Aviv 6997801, Israel.
Ravit BassalDepartment of Epidemiology and Preventive Medicine, School of Public Health, Faculty of Medicine, Tel Aviv University, Tel Aviv 6997801, Israel.
Shiri Meron-SudaiDepartment of Epidemiology and Preventive Medicine, School of Public Health, Faculty of Medicine, Tel Aviv University, Tel Aviv 6997801, Israel.
Sophy GorenDepartment of Epidemiology and Preventive Medicine, School of Public Health, Faculty of Medicine, Tel Aviv University, Tel Aviv 6997801, Israel.
Lital Keinan-BokerIsrael Center for Disease Control, Ministry of Health, Chaim Sheba Medical Center, Tel-Hashomer, Ramat-Gan 52621, Israel.
Calman A MacLennanBill & Melinda Gates Foundation, 62 Buckingham Gate, London SW1E 6QW, UK.
Dani CohenDepartment of Epidemiology and Preventive Medicine, School of Public Health, Faculty of Medicine, Tel Aviv University, Tel Aviv 6997801, Israel.ORCID 0000-0003-2664-2303
Tel Aviv University · ILSheba Medical Center · ILUniversity of Oxford · GB

Funding

Bill & Melinda Gates Foundation Investment (ID OPP1195433)
6 · The paper itself

Abstract

background

objectivesWe examined levels and determinants of serum IgG to

methodsWe analyzed 1096 serum samples from 0- to 19-year-olds collected in 2008-2015 for IgG anti-

resultsIn a multivariable analysis model, children aged 1-4, 5-14, and 15-19 years were 6.71, 27.68, and 48.62 times more likely to have IgG anti-

conclusionsThe study results support anti-

Indexed as

childrenIgGincidenceIsraelShigellashigellosis

Identifiers

PMID38543873
PMCPMC10974432
OpenAlexW4392168638

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.